The European Medicines Agency (EMA) has officially confirmed that semaglutide medicationsincluding Ozempic, Wegovy, and Rybelsuscarry a "very rare" but serious risk of causing nonarteritic anterior ischemic optic neuropathy (NAION) , a serious eye condition that can cause vision loss
Gonzlez-Prez A, Saez M, Vizcaya D, et al
While pathway analysis identified metformin and certain combination therapies as strong candidates for preventing DM2-associated AD by modulating key pathways, MR analysis found no evidence supporting a causal protective relationship between genetically proxied metformin effects and AD risk
I also spent less time on twitter this week compared to last week
2006 diciembre;91(12):5013-8
The intensity of your cardio is evaluated based on your heart rate during exercise